Nmdar Or Lgi1 Mediated Autoimmune Encephalitis clinical trials

Explore recruiting nmdar or lgi1 mediated autoimmune encephalitis clinical trials.

Also recruiting in Europe

Nmdar Or Lgi1 Mediated Autoimmune Encephalitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients with Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis

Netherlands, Denmark, Italy, Czechia, Austria, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nmdar Or Lgi1 Mediated Autoimmune Encephalitis trials by city

Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Toronto Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Vancouver Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Montreal Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Calgary Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Edmonton Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Ottawa Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Winnipeg Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Quebec City Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Hamilton Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Kitchener Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in London Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Halifax Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in New York Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Los Angeles Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Chicago Nmdar Or Lgi1 Mediated Autoimmune Encephalitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease